PubMed

Glycated and oxidized protein degradation products are indicators of fasting and postprandial hyperglycemia in diabetes.

Ahmed N, Babaei-Jadidi R, Howell SK, Thornalley PJ, Beisswenger PJ.

Diabetes Care. 2005 Oct;28(10):2465-71.PMID: 16186281 [PubMed - indexed for MEDLINE]Related articlesFree article

alpha-Dicarbonyls increase in the postprandial period and reflect the degree of hyperglycemia.

Beisswenger PJ, Howell SK, O'Dell RM, Wood ME, Touchette AD, Szwergold BS.

Diabetes Care. 2001 Apr;24(4):726-32.PMID: 11315838 [PubMed - indexed for MEDLINE]Related articlesFree article

Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes.

Ahmed N, Babaei-Jadidi R, Howell SK, Beisswenger PJ, Thornalley PJ.

Diabetologia. 2005 Aug;48(8):1590-603. Epub 2005 Jun 30.PMID: 15988580 [PubMed - indexed for MEDLINE]Related articles

Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product Nepsilon-(carboxymethyl) lysine independently of glycohaemoglobin concentrations.

Hammes HP, Brownlee M, Lin J, Schleicher E, Bretzel RG.

Diabetologia. 1999 May;42(5):603-7.PMID: 10333054 [PubMed - indexed for MEDLINE]Related articles

Optimal administration of lispro insulin in hyperglycemic type 1 diabetes.

Rassam AG, Zeise TM, Burge MR, Schade DS.

Diabetes Care. 1999 Jan;22(1):133-6.PMID: 10333914 [PubMed - indexed for MEDLINE]Related articlesFree article

Prandial insulin substitution with insulin lispro or insulin lispro mid mixture vs. basal therapy with insulin glargine: a randomized controlled trial in patients with type 2 diabetes beginning insulin therapy.

Kazda C, Hülstrunk H, Helsberg K, Langer F, Forst T, Hanefeld M.

J Diabetes Complications. 2006 May-Jun;20(3):145-52.PMID: 16632233 [PubMed - indexed for MEDLINE]Related articles

Pramlintide reduces postprandial glucose excursions when added to regular insulin or insulin lispro in subjects with type 1 diabetes: a dose-timing study.

Weyer C, Gottlieb A, Kim DD, Lutz K, Schwartz S, Gutierrez M, Wang Y, Ruggles JA, Kolterman OG, Maggs DG.

Diabetes Care. 2003 Nov;26(11):3074-9.PMID: 14578242 [PubMed - indexed for MEDLINE]Related articlesFree article

Defining the role of insulin lispro in the management of postprandial hyperglycaemia in patients with type 2 diabetes mellitus.

Giugliano D, Ceriello A, Razzoli E, Esposito K.

Clin Drug Investig. 2008;28(4):199-210. Review.PMID: 18345710 [PubMed - indexed for MEDLINE]Related articles

Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry.

Thornalley PJ, Battah S, Ahmed N, Karachalias N, Agalou S, Babaei-Jadidi R, Dawnay A.

Biochem J. 2003 Nov 1;375(Pt 3):581-92.PMID: 12885296 [PubMed - indexed for MEDLINE]Related articlesFree article

Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes Importance of postprandial glycemia to achieve target HbA1c levels.

Woerle HJ, Neumann C, Zschau S, Tenner S, Irsigler A, Schirra J, Gerich JE, Göke B.

Diabetes Res Clin Pract. 2007 Aug;77(2):280-5. Epub 2007 Jan 22.PMID: 17240473 [PubMed - indexed for MEDLINE]Related articles

Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.

Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.

Clin Ther. 2007 Nov;29(11):2349-64.PMID: 18158076 [PubMed - indexed for MEDLINE]Related articles

Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients.

Hamada Y, Nakamura J, Naruse K, Komori T, Kato K, Kasuya Y, Nagai R, Horiuchi S, Hotta N.

Diabetes Care. 2000 Oct;23(10):1539-44.PMID: 11023149 [PubMed - indexed for MEDLINE]Related articlesFree article

A single-center, randomized, double-blind, three-way crossover study examining postchallenge glucose responses to human insulin 70/30 and insulin lispro fixed mixtures 75/25 and 50/50 in patients with type 2 diabetes mellitus.

Schwartz S, Zagar AJ, Althouse SK, Pinaire JA, Holcombe JH.

Clin Ther. 2006 Oct;28(10):1649-57.PMID: 17157120 [PubMed - indexed for MEDLINE]Related articles

Advanced glycation end products are associated with pulse pressure in type 1 diabetes: the EURODIAB Prospective Complications Study.

Schram MT, Schalkwijk CG, Bootsma AH, Fuller JH, Chaturvedi N, Stehouwer CD; EURODIAB Prospective Complications Study Group.

Hypertension. 2005 Jul;46(1):232-7. Epub 2005 Apr 25.PMID: 15851628 [PubMed - indexed for MEDLINE]Related articlesFree article

Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.

Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C.

JAMA. 2006 Apr 12;295(14):1681-7.PMID: 16609090 [PubMed - indexed for MEDLINE]Related articlesFree article

Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors.

Ceriello A, Del Prato S, Bue-Valleskey J, Beattie S, Gates J, de la Peña A, Malone J.

J Diabetes Complications. 2007 Jan-Feb;21(1):20-7.PMID: 17189870 [PubMed - indexed for MEDLINE]Related articles

Chromatographic assay of glycation adducts in human serum albumin glycated in vitro by derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and intrinsic fluorescence.

Ahmed N, Thornalley PJ.

Biochem J. 2002 May 15;364(Pt 1):15-24.PMID: 11988071 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of advanced glycation endproducts on haemoglobin (Hb-AGE) and haemoglobin A1c for the assessment of diabetic control.

Turk Z, Mesić R, Benko B.

Clin Chim Acta. 1998 Oct;277(2):159-70.PMID: 9853699 [PubMed - indexed for MEDLINE]Related articles

Effects of pramlintide on postprandial glucose excursions and measures of oxidative stress in patients with type 1 diabetes.

Ceriello A, Piconi L, Quagliaro L, Wang Y, Schnabel CA, Ruggles JA, Gloster MA, Maggs DG, Weyer C.

Diabetes Care. 2005 Mar;28(3):632-7.PMID: 15735200 [PubMed - indexed for MEDLINE]Related articlesFree article

Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c).

Monnier L, Lapinski H, Colette C.

Diabetes Care. 2003 Mar;26(3):881-5.PMID: 12610053 [PubMed - indexed for MEDLINE]Related articlesFree article